Traditional Chinese Medicinal Leech Induces Apoptosis and Autophagy in Glioblastoma by SGK1 /Caspase‐3 and PI3K / AKT / mTOR Pathway
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1002/cns.70683 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Shaohua Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: Glioblastoma, Apoptosis, Autophagy, Leeches. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Program of Hunan Provincial Health Commission.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) represents the most lethal form of high‐grade glioma, with current therapeutic options proving largely ineffective. Consequently, there is an urgent need for novel treatment strategies. Recent studies have indicated that the medicinal leech exhibits notable anticancer properties. However, the precise mechanisms underlying these effects remain to be elucidated.
Methods
To investigate the impact of leech drug‐containing serum (LDS) on the proliferation, migration, and invasion of GBM cells, a series of assays including CCK‐8, ethynyl deoxyuridine (EdU), colony formation, scratch, and transwell assays were employed. Additionally, the apoptosis and autophagy of GBM cells were analyzed using flow cytometry, monodansylcadaverine staining and the immunofluorescence assay. Transcriptomic sequencing of the cells was conducted to identify differentially expressed genes. In vivo, anticancer activity was assessed by developing tumor xenograft models. Western blot analysis was utilized to identify proteins associated with apoptosis and autophagy.
Results
Leech drug‐containing serum (LDS) significantly inhibited proliferation, migration, and invasion. Furthermore, it induced autophagy and apoptosis in GBM. Differential gene enrichment analysis and pathway validation indicated that LDS exerts anti‐GBM effects by modulating the PI3K/AKT pathway. Leech extracts effectively inhibit the growth of GBM in a subcutaneous xenograft tumor model.
Conclusion
The leech‐derived compounds may induce apoptosis and autophagy in GBM by modulating the PI3K/AKT/mTOR signaling pathway, without eliciting significant adverse effects, thereby presenting itself as a promising therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Parasitology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, People's Republic of China.
- Institute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
- Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
- Laboratory for Interdisciplinary Science of TCM, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
ORCID-Profile: Yang Wang
Förderung
- Scientific Research Program of Hunan Provincial Health Commission
Zitieren
APA
Wu, S., Zhou, Y., Pei, Z., Wang, Y., & Zhang, Z. (2025). Traditional Chinese Medicinal Leech Induces Apoptosis and Autophagy in Glioblastoma by SGK1 /Caspase‐3 and PI3K / AKT / mTOR Pathway. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70683
Vancouver
Wu S, Zhou Y, Pei Z, Wang Y, Zhang Z. Traditional Chinese Medicinal Leech Induces Apoptosis and Autophagy in Glioblastoma by SGK1 /Caspase‐3 and PI3K / AKT / mTOR Pathway. CNS Neuroscience & Therapeutics. 2025. doi:10.1002/cns.70683
BibTeX
@article{Wu2025,
author = {Wu, Shaohua and Zhou, Yaya and Pei, Zhuan and Wang, Yang and Zhang, Zuping},
title = {Traditional Chinese Medicinal Leech Induces Apoptosis and Autophagy in Glioblastoma by SGK1 /Caspase‐3 and PI3K / AKT / mTOR Pathway},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1002/cns.70683}
}
EUVIMED